Evidence map›Paper›PMID 42828380›Full record

ArticleCureus2026

Steroid-Refractory Adult-Onset Still's Disease: A Case Report.

Pyae Phyo Kyaw, Thapye Mon, Pyae Phyo Thu, Aye Nyein

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pyae Phyo KyawAcute Medicine, Heartlands Hospital, Birmingham, GBR.
Thapye MonInternal Medicine, Heartlands Hospital, Birmingham, GBR.
Pyae Phyo ThuAcute Medicine, Heartlands Hospital, Birmingham, GBR.
Aye NyeinPulmonology, Queen Elizabeth Hospital Birmingham, Birmingham, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult-onset Still's disease (AOSD) is one of the systemic autoinflammatory disorders characterised by an evanescent salmon-pink rash, high spiking fevers, and inflammatory arthritis. AOSD is driven by dysregulated immune activation involving excess pro-inflammatory cytokines, specifically IL-1β and IL-18. Current consensus recognises AOSD and systemic juvenile idiopathic arthritis as a continuous disease spectrum. Because it lacks a definitive biomarker and mimics other severe conditions, AOSD remains a diagnosis of exclusion; early recognition is paramount to prevent complications including macrophage activation syndrome and haemophagocytic lymphohistiocytosis. We report the case of a 23-year-old man presenting with persistent pyrexia of unknown origin, an evanescent rash, inflammatory monoarthritis, marked neutrophilic leukocytosis, and profound hyperferritinaemia. Following an extensive multidisciplinary investigation to exclude connective tissue disease, malignancy, and infection, the patient successfully fulfilled the Yamaguchi classification criteria for AOSD. This case highlights the inherent diagnostic challenges associated with Still's disease. It demonstrates the critical importance of early multidisciplinary assessment and the timely escalation to targeted cytokine-directed therapies to achieve disease remission.

Indexed as

adult-onset still’s diseasebiological therapyfever of unknown originhyperferritinemiainterleukin-6

Identifiers

PMID42828380
PMCPMC13632789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.